Literature DB >> 11748553

Malignant biliary disease: percutaneous interventions.

R A Morgan1, A N Adam.   

Abstract

Interventional radiologists have an important role in the management of patients with malignant biliary obstruction. This article describes the techniques for percutaneous biliary drainage, insertion of biliary endoprostheses, and the management of occluded biliary endoprostheses. Most procedures are performed by using fluoroscopic guidance alone. Ultrasound is also a useful modality for guiding biliary drainage, particularly drainage of the left biliary ducts. Patients should be treated by internal drainage if possible. Metallic endoprostheses can be inserted at the time of the initial biliary drainage procedure. Plastic tubes should be inserted a few days after biliary drainage because of their relatively large size compared with metallic stents. Occluded plastic stents should be replaced. Blocked metallic stents should be treated either by placement of additional overlapping metallic stents or by placement of plastic stents within the metallic stent lumen. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2001        PMID: 11748553     DOI: 10.1016/s1089-2516(01)90021-6

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  3 in total

Review 1.  [Radiological interventional procedures for the acute abdomen].

Authors:  C Trumm; R-T Hoffmann; M F Reiser
Journal:  Radiologe       Date:  2010-03       Impact factor: 0.635

2.  Percutaneous trans-hepatic bilateral biliary stenting in Bismuth IV malignant obstruction.

Authors:  Dimitrios Karnabatidis; Stavros Spiliopoulos; Paraskevi Katsakiori; Odissefs Romanos; Konstantinos Katsanos; Dimitrios Siablis
Journal:  World J Hepatol       Date:  2013-03-27

3.  Embolization for delayed arterial bleeding after percutaneous self-expandable metallic stent placement in patients with malignant biliary obstruction.

Authors:  Pyeong Hwa Kim; Jong Woo Kim; Dong Il Gwon; Gi-Young Ko; Ji Hoon Shin; Hyun-Ki Yoon
Journal:  Br J Radiol       Date:  2019-12-11       Impact factor: 3.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.